2026 product information confirms a seven-ingredient capsule formula containing Tongkat Ali, Epimedium extract, saw palmetto, wild yam, sarsaparilla, nettle and boron, with two capsules listed as the daily serving
OGDEN, Utah, September 26, 2026 — HoneyPower has published updated 2026 U.S. formula and label information for its stimulant-free dietary supplement for adult men, providing a consolidated description of the current ingredient list, serving directions, manufacturing information and research limitations associated with the seven-ingredient formula.
The current HoneyPower formula identifies six botanical ingredients — Tongkat Ali, Epimedium extract, saw palmetto, wild yam, sarsaparilla and nettle — together with the trace mineral boron.
Product information lists a serving of two capsules per day with water. HoneyPower also confirms that the current formulation does not contain caffeine or other stimulant ingredients.
The new product-information overview is intended to distinguish basic label facts from findings reported in studies involving individual ingredients. Research involving a botanical by itself does not establish the effects of a finished multi-ingredient supplement, particularly when studies use different extracts, quantities, populations or treatment periods.
“The purpose of the updated information is straightforward: clearly identify what is in the current formula, explain how it is intended to be used and keep individual-ingredient research separate from conclusions about the complete product,” said Kevin Moore, Product Head at HoneyPower. “A clinical study of one botanical is information about that ingredient under the conditions of the study. It should not automatically be presented as evidence for a seven-ingredient formula.”
Current HoneyPower Formula
HoneyPower is supplied as a capsule supplement for adult men.
The current formula contains:
-
Tongkat Ali (Eurycoma longifolia)
-
Epimedium extract
-
Saw palmetto (Serenoa repens)
-
Wild yam (Dioscorea villosa)
-
Sarsaparilla
-
Nettle (Urtica dioica)
-
Boron
The recommended serving identified in current product information is two capsules per day with water. HoneyPower is also formulated without caffeine or other stimulants.
The absence of caffeine is a product specification rather than an efficacy claim. Botanical ingredients can still have physiological activity and may interact with medications, medical conditions or other dietary supplements.
Consumers should therefore evaluate the complete ingredient list rather than assuming that a stimulant-free product is appropriate for every individual.
Why HoneyPower Is Publishing Updated Formula Information
Multi-ingredient dietary supplements are often discussed using findings taken from studies of isolated ingredients.
That can create confusion.
A controlled human study typically identifies:
-
the exact botanical or nutrient used;
-
the preparation or extract;
-
the quantity administered;
-
the characteristics of participants;
-
how long the intervention lasted; and
-
the measurements researchers evaluated.
Changing any of those factors can affect the relevance of a study.
HoneyPower combines seven ingredients within one daily supplement. The finished HoneyPower formulation has not been evaluated in the individual studies referenced in its existing ingredient information.
The 2026 product overview therefore separates three different types of information:
-
what the HoneyPower product label identifies;
-
what independent research has examined concerning individual ingredients; and
-
what has actually been demonstrated for the complete HoneyPower formulation.
The third question cannot be answered simply by combining the results of unrelated studies.
Tongkat Ali: Study Results Depend on the Extract and Research Design
Tongkat Ali is a botanical native to Southeast Asia with a history of traditional use.
Modern research has evaluated standardized Tongkat Ali preparations in several contexts.
One randomized, placebo-controlled study involving 63 moderately stressed adults examined a standardized root extract over four weeks.
Researchers measured several biological and self-reported indicators during the study and reported differences between the treatment and placebo groups for some measurements.
The study nevertheless has important limitations when used to discuss a commercial multi-ingredient supplement.
It involved a specific standardized extract, a defined quantity and a relatively short intervention period.
Tongkat Ali preparations can differ in plant source, extraction method and standardization.
HoneyPower therefore does not treat the results from a particular Tongkat Ali study as evidence that the complete HoneyPower formula will produce the same findings.
The study provides research context for the botanical itself.
Saw Palmetto: Large Controlled Trials Illustrate Why Null Findings Matter
Saw palmetto is among the more extensively studied botanicals appearing in the current HoneyPower formula.
A large randomized, double-blind, placebo-controlled trial published in the New England Journal of Medicine followed 225 men for one year.
Researchers compared saw palmetto extract with placebo using established clinical measurements.
The study did not find a significant difference between groups for the principal outcomes being measured.
Later research has also produced results that do not consistently demonstrate effects across preparations and study populations.
This is relevant to the way HoneyPower presents ingredient research.
Null results are still research results.
The company does not use the presence of saw palmetto in its formula to make conclusions that were not established in controlled studies.
People experiencing persistent health symptoms should seek appropriate medical evaluation rather than relying on a dietary supplement to diagnose or manage a medical condition.
Boron: A Trace Mineral With Limited Human Research
Boron is a naturally occurring trace element present in foods including nuts, legumes, fruits and vegetables.
The National Institutes of Health Office of Dietary Supplements notes that boron has not been classified as an essential nutrient for humans.
It has nevertheless been investigated in relation to several biological processes.
One small human study administered 10 mg of boron daily for one week to eight participants and examined a range of blood measurements.
Because the trial involved only eight people and lasted seven days, its findings should be considered preliminary.
A small exploratory study cannot establish a general result for a broad adult population.
It also cannot establish a result for HoneyPower.
The NIH identifies a tolerable upper intake level of 20 mg of boron per day for adults.
People taking several supplements should therefore review their combined boron intake using the quantities shown on their product labels.
Wild Yam: Plant Chemistry Should Not Be Confused With Human Metabolism
Wild yam contains a naturally occurring plant compound known as diosgenin.
Diosgenin has industrial importance because laboratories can use it as a chemical starting material in the manufacture of certain compounds.
That laboratory process does not mean the human body performs the same chemical conversion after consuming wild yam.
This distinction is important because plant chemistry is sometimes simplified when botanical supplements are discussed.
HoneyPower identifies wild yam as one botanical component of its formula but does not present the ingredient as a replacement for medical treatment or as a source of pharmaceutical compounds.
Research concerning a chemical extracted from a plant should also be distinguished from research involving consumption of the whole botanical or a commercial supplement.
Epimedium: Human Evidence Remains More Limited
Epimedium is a genus of flowering plants used historically in traditional botanical practices.
It contains several naturally occurring compounds, including flavonoids that have been examined in laboratory and animal research.
Human clinical evidence is considerably more limited.
Laboratory studies can help researchers understand biological mechanisms, but findings produced in cells or experimental animal models cannot automatically be translated into effects in humans.
Likewise, research involving a concentrated isolated compound cannot establish what occurs when an Epimedium extract is consumed as one ingredient within a multi-botanical supplement.
HoneyPower therefore identifies Epimedium as part of its formula without describing laboratory findings as clinical evidence for the finished product.
Sarsaparilla and Nettle: Traditional Use Does Not Equal Clinical Proof
Sarsaparilla and nettle are two additional botanicals included in HoneyPower.
Sarsaparilla refers to plants within the Smilax genus and has a history of use in traditional herbal preparations.
The plant contains several naturally occurring compounds that remain subjects of scientific research.
However, a history of traditional use should not be treated as equivalent to evidence from randomized controlled human trials.
Nettle has also been used traditionally in multiple regions.
Both the leaf and root of Urtica dioica have appeared in botanical research, and the part of the plant being studied matters when evaluating the evidence.
Results involving a nettle root preparation, for example, should not automatically be transferred to a differently prepared nettle ingredient.
HoneyPower identifies sarsaparilla and nettle as botanical components without assigning product-level outcomes to either ingredient.
What Published Ingredient Research Can Establish
The updated HoneyPower information emphasizes that ingredient research has value when it is presented in the context in which it was conducted.
A study can establish what researchers observed:
-
using a particular ingredient;
-
at a particular quantity;
-
in a defined group;
-
for a specified period; and
-
using predetermined measurements.
The study does not automatically establish the same findings for another product.
This distinction becomes particularly important with multi-ingredient dietary supplements.
HoneyPower combines seven ingredients rather than a single isolated botanical.
The interaction of those components and their combined effect cannot be determined by adding together conclusions from separate research papers.
For that reason, HoneyPower does not describe its complete formula as clinically proven based solely on independent ingredient studies.
“Good research reporting includes the limitations as well as the findings,” Moore said. “If one trial reports a result and another study reports no significant difference, both pieces of information matter. The purpose is to describe the evidence accurately rather than turn every ingredient study into a product claim.”
Stimulant-Free Formulation
HoneyPower’s current formula does not include caffeine or another stimulant ingredient. That specification may be relevant to consumers who already obtain caffeine from coffee, tea, energy drinks or other dietary products.
However, stimulant-free does not mean interaction-free. Botanical compounds can affect people differently depending on health status, medication use, other supplements and individual sensitivity.
Consumers should therefore review all seven ingredients when deciding whether the product is appropriate for their circumstances.
Safety and Suitability
HoneyPower is intended for adult use. Consumers taking prescription medication or managing an existing health condition should discuss dietary supplements with an appropriate healthcare professional.
Particular consideration may be appropriate for individuals who:
-
take blood-pressure medication;
-
use blood-thinning medication;
-
take diabetes medication;
-
use prescription treatments that may interact with botanical supplements;
-
are scheduled for surgery;
-
use multiple botanical products; or
-
obtain boron from other dietary supplements.
Consumers should follow the serving directions provided on the current physical product label.
A research study using a larger amount of an individual botanical is not a reason to exceed the product’s recommended serving.
The Supplement Facts panel and package labeling should remain the primary sources for current ingredient quantities, serving information and warnings.
Manufacturing Information
HoneyPower states that the current product is manufactured in the United States in a facility registered with the U.S. Food and Drug Administration and operating under current Good Manufacturing Practice requirements.
FDA facility registration and manufacturing requirements should not be confused with FDA approval of a dietary supplement.
Unlike pharmaceutical drugs, dietary supplements are not individually approved by the FDA before they are marketed.
Manufacturing information therefore describes production and quality-control requirements rather than evidence that a product has been clinically evaluated by the agency.
U.S. Product Information and Availability
HoneyPower is currently available to adult consumers in the United States. The product is supplied in capsule form, with current directions identifying two capsules per day with water.
The 2026 information update consolidates the current seven-ingredient formula, stimulant-free specification, serving information, manufacturing details and evidence limitations in a single product-information resource.
Consumers should rely on the physical label supplied with their product for the most current formula, serving instructions and warnings because product specifications may change.
About HoneyPower
HoneyPower is a U.S.-based dietary supplement brand focused on men’s wellness. Its current stimulant-free capsule formula contains Tongkat Ali, Epimedium extract, saw palmetto, wild yam, sarsaparilla, nettle and boron.
HoneyPower publishes product information and ingredient research separately so findings involving individual ingredients are not represented as clinical evaluation of the complete formulation.
References
-
Talbott SM, Talbott JA, George A, Pugh M. Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition. 2013;10:28.
-
Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. New England Journal of Medicine. 2006;354(6):557–566.
-
Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour MS. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. Journal of Trace Elements in Medicine and Biology. 2011;25(1):54–58.
-
National Institutes of Health, Office of Dietary Supplements. Boron — Fact Sheet for Health Professionals.
-
Memorial Sloan Kettering Cancer Center. About Herbs: Wild Yam.
Media Contact
Kevin Moore
Product Head
HoneyPower
11870 62nd St. N, Largo, FL 33773
Email: support@honeypower.us
Phone: +1 (877) 257-0825
Website: honeypower.us
These statements have not been evaluated by the U.S. Food and Drug Administration. HoneyPower is a dietary supplement and is not intended to diagnose, treat, cure or prevent any disease. Research referenced in this release concerns individual ingredients studied independently and does not constitute clinical evaluation of the complete HoneyPower formulation or endorsement by the cited researchers, journals, institutions or government agencies.
